Medicamen Organics IPO GMP Guidance & Subscription Status at Chanakyanipothi.com,
👉A legacy of 31 Years.
India`s Oldest Investment & IPO website.
👉Most Trusted by Investors across India.

Table of Contents

What is the business of Medicamen Organics?

Medicamen Organics is engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government (including both state and central governments) and private institutions as contract manufacturer / third party manufacturer. It markets its product to private pharma companies in domestic as well as international markets through third party distributors
or on loan license basis. Further, the Company is also strategically focusing on establishing a direct presence in international market for an instance in fiscal 2023, it has directly exported its product in Burundi. It has a track record of operating B2B model which covers contract manufacturing model. Its products are marketed across India as well as African, CIS and south East Asian Countries like Congo, Benin, Cameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya by its third-party distributor.
It has 2 WHO GMP approved manufacturing facilities located at 60 and 61, Sector 6A, I.I.E. SIDCUL, Ranipur, Haridwar 249403, Uttarakhand spread across 21,536 Sq. Ft. Its manufacturing facilities are capable of producing pharmaceutical formulations and products and has fully equipped quality control department with experienced and qualified staff to facilitate smooth manufacturing process. It has in-house testing laboratory and necessary infrastructure to test its raw materials and
finished products to match the quality standards. It is ISO 9001:2015 certified company. Its core strength lies in product development and documentation, which gives it an inherent strength in the market as we are regularly engaged in research and development and launching new products. This gives it an ever-evolving product list as well as better pricing in the market.
Its product portfolio consists of 84 products and comprises of wide range of drugs like, Anti-Bacterial, Anti Diarrheal, Anti Fungal, Anti-Malarial, Anti Diabetic, Proton Pump Inhibitor, Anti Histamine, Anti-Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral and Non-steroidal anti-inflammatory drug (NSAIDS).
The Company is consistent in supplying of quality products round the year. Its products comply with requisite safety standards.
It is a quality conscious company. It is constantly striving to expand its line of products and it is always looking for complementary products that will add to its range of products.

Get more information about the company @ http://www.medicamenorganics.cohttp://www.medicamenorganics.com/

Who are the Promoters of Medicamen Organics IPO?
Mr. Ranjit Kulladhaja Mayengbam and Mrs. Gangarani Devi Mayengbam are the company’s promoters

What are the Objects of Medicamen Organics IPO?

The Offer comprises of a Fresh Issue of Equity shares & also offer for sale.

The company intends to utilize the proceeds of the Offer to meet the following objects: –

1. Funding Working Capital Requirements of the Company

2. Repayment/ Prepayment of Certain Borrowings availed by the Company

3. General corporate purposes

Medicamen Organics IPO To the point Guidance
Medicamen Organics is engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government (including both state and central governments) and private institutions as contract manufacturer / third party manufacturer. It markets its product to private pharma companies in domestic as well as international markets through third party distributors
or on loan license basis.
Size:  The net offer is of Rs. 10.854 Crore/3100000 shares. Retail portion is Rs. 3.48 crore and it can get one time subscribed with 261 applications. The size of the IPO is not very large, looking to the investor frenzy and one time over subscription may not be an issue. 
Financial Snapshot: The net profit has increased to Rs. 90 lac during 2022-23 from just Rs. 30 lac in 2020-21. We are not sure whether the company can maintain such high profits in the coming years. The brand is strong. Small application be made.

Quicklinks

• Staffavailable.com
• BigGaddi.com
• ChanakyaMFGuidance.com
• Magajmari.com
• AnalysisLibrary.com

Medicamen Organics IPO GMP today details?

Medicamen Organics IPO

Medicamen Organics IPO FAQs

What is Medicamen Organics IPO?
Medicamen Organics is a SME IPO of 2200000 equity shares of the face value of Rs. 5 aggregating up to Rs.11.44 Crores. The issue is priced at Rs.52 per share. The minimum order quantity is 2000 Shares.

When will Medicamen Organics IPO open?
Medicamen Organics IPO opens on June 21, 2024, and closes on June 25, 2024.

What is the lot size of Medicamen Organics IPO?
Medicamen Organics IPO lot size is 4000 Shares, and the minimum amount required is Rs.136000.

How to apply for Medicamen Organics IPO?
You can apply in Medicamen Organics IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don’t offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.

When is Medicamen Organics IPO allotment?
The finalization of Basis of Allotment for Medicamen Organics IPO will be done on 26 June, 2024, and the allotted shares will be credited to your demat account by June 27, 2024.

When is Medicamen Organics IPO listing date?
Medicamen Organics IPO listing date is June 28, 2024.